The Diasporin Pathway

A tumor progression-related transcriptional network that predicts breast cancer survival

Nigel P.S. Crawford, Renard C. Walker, Luanne Lukes, Jennifer S. Officewala, Robert Williams, Kent W. Hunter

Research output: Contribution to journalArticle

51 Citations (Scopus)

Abstract

Microarray expression signature analyses have suggested that extracellular matrix (ECM) gene dysregulation is predictive of metastasis in both mouse mammary tumorigenesis and human breast cancer. We have previously demonstrated that such ECM dysregulation is influenced by hereditary germline-encoded variation. To identify novel metastasis efficiency modifiers, we performed expression QTL (eQTL) mapping in recombinant inbred mice by characterizing genetic loci modulating metastasis-predictive ECM gene expression. Three reproducible eQTLs were observed on chromosomes 7, 17 and 18. Candidate genes were identified by correlation analyses and known associations with metastasis. Seven candidates were identified (Ndn, Pi16, Luc7l, Rrp1b, Brd4, Centd3 and Csf1r). Stable transfection of the highly metastatic Mvt-1 mouse mammary tumor cell line with expression vectors encoding each candidate modulated metastasis-predictive ECM gene expression. Implantation of these cells into mice demonstrated that candidate gene ectopic expression impacts tumor progression. Gene expression analyses facilitated the construction of a transcriptional network that we have termed the 'Diasporin Pathway'. This pathway contains the seven candidates, as well as metastasis-predictive ECM genes and metastasis suppressors. Brd4 and Rrp1b appear to form a central node within this network, which likely is a consequence of their physical interaction with the metastasis efficiency modifier Sipa1. Furthermore, we demonstrate that the microarray gene expression signatures induced by activation of ECM eQTL genes in the Mvt-1 cell line can be used to accurately predict survival in a human breast cancer cohort. These data imply that the Diasporin Pathway may be an important nexus in tumor progression in both mice and humans.

Original languageEnglish (US)
Pages (from-to)357-369
Number of pages13
JournalClinical and Experimental Metastasis
Volume25
Issue number4
DOIs
StatePublished - Jun 1 2008

Fingerprint

Gene Regulatory Networks
Extracellular Matrix
Breast Neoplasms
Neoplasm Metastasis
Survival
Neoplasms
Gene Expression
Chromosomes, Human, Pair 18
Chromosomes, Human, Pair 17
Chromosomes, Human, Pair 7
Genetic Loci
Tumor Cell Line
Tumor Suppressor Genes
Transcriptome
Genes
Transfection
Carcinogenesis
Breast
Cell Line

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

The Diasporin Pathway : A tumor progression-related transcriptional network that predicts breast cancer survival. / Crawford, Nigel P.S.; Walker, Renard C.; Lukes, Luanne; Officewala, Jennifer S.; Williams, Robert; Hunter, Kent W.

In: Clinical and Experimental Metastasis, Vol. 25, No. 4, 01.06.2008, p. 357-369.

Research output: Contribution to journalArticle

Crawford, Nigel P.S. ; Walker, Renard C. ; Lukes, Luanne ; Officewala, Jennifer S. ; Williams, Robert ; Hunter, Kent W. / The Diasporin Pathway : A tumor progression-related transcriptional network that predicts breast cancer survival. In: Clinical and Experimental Metastasis. 2008 ; Vol. 25, No. 4. pp. 357-369.
@article{d226e9207fb5422baf927fbeb5b4d9ee,
title = "The Diasporin Pathway: A tumor progression-related transcriptional network that predicts breast cancer survival",
abstract = "Microarray expression signature analyses have suggested that extracellular matrix (ECM) gene dysregulation is predictive of metastasis in both mouse mammary tumorigenesis and human breast cancer. We have previously demonstrated that such ECM dysregulation is influenced by hereditary germline-encoded variation. To identify novel metastasis efficiency modifiers, we performed expression QTL (eQTL) mapping in recombinant inbred mice by characterizing genetic loci modulating metastasis-predictive ECM gene expression. Three reproducible eQTLs were observed on chromosomes 7, 17 and 18. Candidate genes were identified by correlation analyses and known associations with metastasis. Seven candidates were identified (Ndn, Pi16, Luc7l, Rrp1b, Brd4, Centd3 and Csf1r). Stable transfection of the highly metastatic Mvt-1 mouse mammary tumor cell line with expression vectors encoding each candidate modulated metastasis-predictive ECM gene expression. Implantation of these cells into mice demonstrated that candidate gene ectopic expression impacts tumor progression. Gene expression analyses facilitated the construction of a transcriptional network that we have termed the 'Diasporin Pathway'. This pathway contains the seven candidates, as well as metastasis-predictive ECM genes and metastasis suppressors. Brd4 and Rrp1b appear to form a central node within this network, which likely is a consequence of their physical interaction with the metastasis efficiency modifier Sipa1. Furthermore, we demonstrate that the microarray gene expression signatures induced by activation of ECM eQTL genes in the Mvt-1 cell line can be used to accurately predict survival in a human breast cancer cohort. These data imply that the Diasporin Pathway may be an important nexus in tumor progression in both mice and humans.",
author = "Crawford, {Nigel P.S.} and Walker, {Renard C.} and Luanne Lukes and Officewala, {Jennifer S.} and Robert Williams and Hunter, {Kent W.}",
year = "2008",
month = "6",
day = "1",
doi = "10.1007/s10585-008-9146-6",
language = "English (US)",
volume = "25",
pages = "357--369",
journal = "Clinical and Experimental Metastasis",
issn = "0262-0898",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - The Diasporin Pathway

T2 - A tumor progression-related transcriptional network that predicts breast cancer survival

AU - Crawford, Nigel P.S.

AU - Walker, Renard C.

AU - Lukes, Luanne

AU - Officewala, Jennifer S.

AU - Williams, Robert

AU - Hunter, Kent W.

PY - 2008/6/1

Y1 - 2008/6/1

N2 - Microarray expression signature analyses have suggested that extracellular matrix (ECM) gene dysregulation is predictive of metastasis in both mouse mammary tumorigenesis and human breast cancer. We have previously demonstrated that such ECM dysregulation is influenced by hereditary germline-encoded variation. To identify novel metastasis efficiency modifiers, we performed expression QTL (eQTL) mapping in recombinant inbred mice by characterizing genetic loci modulating metastasis-predictive ECM gene expression. Three reproducible eQTLs were observed on chromosomes 7, 17 and 18. Candidate genes were identified by correlation analyses and known associations with metastasis. Seven candidates were identified (Ndn, Pi16, Luc7l, Rrp1b, Brd4, Centd3 and Csf1r). Stable transfection of the highly metastatic Mvt-1 mouse mammary tumor cell line with expression vectors encoding each candidate modulated metastasis-predictive ECM gene expression. Implantation of these cells into mice demonstrated that candidate gene ectopic expression impacts tumor progression. Gene expression analyses facilitated the construction of a transcriptional network that we have termed the 'Diasporin Pathway'. This pathway contains the seven candidates, as well as metastasis-predictive ECM genes and metastasis suppressors. Brd4 and Rrp1b appear to form a central node within this network, which likely is a consequence of their physical interaction with the metastasis efficiency modifier Sipa1. Furthermore, we demonstrate that the microarray gene expression signatures induced by activation of ECM eQTL genes in the Mvt-1 cell line can be used to accurately predict survival in a human breast cancer cohort. These data imply that the Diasporin Pathway may be an important nexus in tumor progression in both mice and humans.

AB - Microarray expression signature analyses have suggested that extracellular matrix (ECM) gene dysregulation is predictive of metastasis in both mouse mammary tumorigenesis and human breast cancer. We have previously demonstrated that such ECM dysregulation is influenced by hereditary germline-encoded variation. To identify novel metastasis efficiency modifiers, we performed expression QTL (eQTL) mapping in recombinant inbred mice by characterizing genetic loci modulating metastasis-predictive ECM gene expression. Three reproducible eQTLs were observed on chromosomes 7, 17 and 18. Candidate genes were identified by correlation analyses and known associations with metastasis. Seven candidates were identified (Ndn, Pi16, Luc7l, Rrp1b, Brd4, Centd3 and Csf1r). Stable transfection of the highly metastatic Mvt-1 mouse mammary tumor cell line with expression vectors encoding each candidate modulated metastasis-predictive ECM gene expression. Implantation of these cells into mice demonstrated that candidate gene ectopic expression impacts tumor progression. Gene expression analyses facilitated the construction of a transcriptional network that we have termed the 'Diasporin Pathway'. This pathway contains the seven candidates, as well as metastasis-predictive ECM genes and metastasis suppressors. Brd4 and Rrp1b appear to form a central node within this network, which likely is a consequence of their physical interaction with the metastasis efficiency modifier Sipa1. Furthermore, we demonstrate that the microarray gene expression signatures induced by activation of ECM eQTL genes in the Mvt-1 cell line can be used to accurately predict survival in a human breast cancer cohort. These data imply that the Diasporin Pathway may be an important nexus in tumor progression in both mice and humans.

UR - http://www.scopus.com/inward/record.url?scp=44449099054&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44449099054&partnerID=8YFLogxK

U2 - 10.1007/s10585-008-9146-6

DO - 10.1007/s10585-008-9146-6

M3 - Article

VL - 25

SP - 357

EP - 369

JO - Clinical and Experimental Metastasis

JF - Clinical and Experimental Metastasis

SN - 0262-0898

IS - 4

ER -